To fulfill this need, we evaluated the genomic alterations of 411 telomere maintenance (TM) genes in 9282 samples from 31 Pan-Cancer Atlas (PCA) studies and applied different in silico approaches with the aim to identify and propose a set of genes which after ex-vivo validations could be used as potential molecular markers to improve the study of the ALT pathway. This evidence concerns the gene GPT and cancer.